Skip to main content

3 Reasons to Sell SHW and 1 Stock to Buy Instead

SHW Cover Image

Since August 2025, Sherwin-Williams has been in a holding pattern, posting a small loss of 0.6% while floating around $365.78. The stock also fell short of the S&P 500’s 6.7% gain during that period.

Is now the time to buy Sherwin-Williams, or should you be careful about including it in your portfolio? Get the full breakdown from our expert analysts, it’s free.

Why Is Sherwin-Williams Not Exciting?

We're sitting this one out for now. Here are three reasons you should be careful with SHW and a stock we'd rather own.

1. Long-Term Revenue Growth Disappoints

Reviewing a company’s long-term sales performance reveals insights into its quality. Any business can experience short-term success, but top-performing ones enjoy sustained growth for years. Regrettably, Sherwin-Williams’s sales grew at a tepid 5.1% compounded annual growth rate over the last five years. This was below our standard for the industrials sector.

Sherwin-Williams Quarterly Revenue

2. Projected Revenue Growth Is Slim

Forecasted revenues by Wall Street analysts signal a company’s potential. Predictions may not always be accurate, but accelerating growth typically boosts valuation multiples and stock prices while slowing growth does the opposite.

Over the next 12 months, sell-side analysts expect Sherwin-Williams’s revenue to rise by 4.2%. Although this projection indicates its newer products and services will fuel better top-line performance, it is still below average for the sector.

3. EPS Barely Growing

Analyzing the long-term change in earnings per share (EPS) shows whether a company's incremental sales were profitable – for example, revenue could be inflated through excessive spending on advertising and promotions.

Sherwin-Williams’s unimpressive 6.9% annual EPS growth over the last five years aligns with its revenue performance. On the bright side, this tells us its incremental sales were profitable.

Sherwin-Williams Trailing 12-Month EPS (Non-GAAP)

Final Judgment

Sherwin-Williams isn’t a terrible business, but it doesn’t pass our quality test. With its shares underperforming the market lately, the stock trades at 30.9× forward P/E (or $365.78 per share). Beauty is in the eye of the beholder, but we don’t really see a big opportunity at the moment. We're fairly confident there are better investments elsewhere. Let us point you toward a safe-and-steady industrials business benefiting from an upgrade cycle.

Stocks We Would Buy Instead of Sherwin-Williams

The market’s up big this year - but there’s a catch. Just 4 stocks account for half the S&P 500’s entire gain. That kind of concentration makes investors nervous, and for good reason. While everyone piles into the same crowded names, smart investors are hunting quality where no one’s looking - and paying a fraction of the price. Check out the high-quality names we’ve flagged in our Top 5 Strong Momentum Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 244% over the last five years (as of June 30, 2025).

Stocks that have made our list include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+354% five-year return). Find your next big winner with StockStory today.

Recent Quotes

View More
Symbol Price Change (%)
AMZN  204.09
-0.70 (-0.34%)
AAPL  261.92
-2.43 (-0.92%)
AMD  201.35
+1.23 (0.61%)
BAC  52.38
-0.98 (-1.83%)
GOOG  304.94
+1.00 (0.33%)
META  644.50
+1.28 (0.20%)
MSFT  397.88
-1.72 (-0.43%)
NVDA  186.38
-1.59 (-0.85%)
ORCL  157.15
+0.98 (0.62%)
TSLA  410.05
-1.27 (-0.31%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.